You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories/Geisinger Proven Diagnostics Test Catalog
CHLAMYDIA/NEISSERIA GONORRHOEAE RNA, TMA, THROAT |
||
ORDERING INFORMATION: |
Geisinger Epic Procedure Code: LAB1015 Geisinger Epic ID: 51985 | |
SPECIMEN COLLECTION |
||
Specimen type: |
1 throat swab in Aptima® transport tube | |
Preferred collection container: |
||
Specimen required: |
1 throat swab in Aptima® Transport Tube | |
Special notes: |
Use the Aptima® Unisex Swab Specimen Collection Kit (white label) or Aptima® Vaginal Swab Specimen Collection Kit or Multi-test Collection Kit (orange label). Using a tongue depressor, insert the small, blue-shafted collection swab (unisex kit, not the white-shafted cleansing swab) or the small pink-shafted collection swab (vaginal or multi-test kit) and vigorously rub the tonsils and the posterior pharynx. Carefully remove the swab without touching any area of the mouth. Remove the cap from the swab specimen transport tube and immediately place the swab into the transport tube. Carefully break the swab shaft at the score line. Re-cap the swab specimen transport tube tightly, label and ship to the lab. | |
| SPECIMEN PROCESSING |
||
Transport temperature: |
Room temperature. | |
Specimen stability: |
Room temperature: 30 days. Refrigerated: 30 days. Frozen: 30 days. | |
Rejection criteria: |
Transport tubes with 2 swabs. Transport tubes with non-Aptima® swabs. Swab transport tubes with no swab. Specimens in broken containers. Swab submitted in viral transport media. | |
TEST DETAILS |
||
Interpretation guide: |
Results from the Aptima® Combo 2 Assay should be interpreted in conjunction with other laboratory and clinical data available to the clinician. The Aptima® Combo 2 Assay is not intended for the evaluation of suspected sexual abuse or for other medico-legal indications. | |
Additional information: |
The analytical performance characteristics of this assay have been determined by Quest Diagnostics. The modifications have not been cleared or approved by the FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. | |
CPT code(s): |
87491, 87591 | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Test includes: |
C. trachomatis TMA, Throat; N. gonorrhoeae TMA, Throat. | |
Methodology: |
Transcription-Mediated Amplification (TMA) |
|
Synonyms: |
CT/NG Aptima,CT/GC Aptima,CT/GC TMA,CT/NG TMA, Quest test code 70051, Ctng Throat
|
|
Clinical significance: |
Chlamydia/Neisseria gonorrhoeae RNA, TMA, Throat - Both Chlamydia trachomatis and Neisseria gonorrhoeae may infect the oral/pharyngeal cavity of sexually active individuals. Detection of this organism may be important for determining the risk for disease progression or transmission. | |